Furthermore, it has been demonstrated that the CP, in AD and aging, is also characterized by amyloid-beta (Aβ) deposition that may disrupt various functions of the CP through impeding underlying biochemical pathways [55-58]. The gene discussed is CP; the disease is Alzheimer disease.